AR118658A2 - COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF THE ALAS1 GENE - Google Patents

COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF THE ALAS1 GENE

Info

Publication number
AR118658A2
AR118658A2 ARP200101035A ARP200101035A AR118658A2 AR 118658 A2 AR118658 A2 AR 118658A2 AR P200101035 A ARP200101035 A AR P200101035A AR P200101035 A ARP200101035 A AR P200101035A AR 118658 A2 AR118658 A2 AR 118658A2
Authority
AR
Argentina
Prior art keywords
alas1
dsrna
expression
compositions
seq
Prior art date
Application number
ARP200101035A
Other languages
Spanish (es)
Original Assignee
Icahn School Med Mount Sinai
Alnylam Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icahn School Med Mount Sinai, Alnylam Pharmaceuticals Inc filed Critical Icahn School Med Mount Sinai
Publication of AR118658A2 publication Critical patent/AR118658A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Composiciones de ácido ribonucleico bicatenario (dsARN) opcionalmente conjugados a un ligando tal como n-acetilgalactosamina. Los dsARN dirigidas al gen ALAS1. Métodos de uso de tales composiciones de dsARN para alterar (por ejemplo, inhibir) la expresión de ALAS1, tal como tratamientos de sujetos con porfiria. Reivindicación 1: Un ácido ribonucleico bicatenario (dsARN) para inhibir la expresión de ALAS1, en donde dicho dsARN comprende una cadena con sentido y una cadena antisentido, donde la cadena antisentido comprende una región de complementariedad con un transcripto de ARN de ALAS1 (por ejemplo, SEQ ID Nº 1), cuya cadena antisentido comprende al menos 20 nucleótidos contiguos de la secuencia antisentido de UAAGAUGAGACACUCUUUCUGGU (SEQ ID Nº 4153) o UAAGAUGAGACACUCTUUCUGGU (SEQ ID Nº 4154).Double stranded ribonucleic acid (dsRNA) compositions optionally conjugated to a ligand such as n-acetylgalactosamine. The dsRNAs directed to the ALAS1 gene. Methods of using such dsRNA compositions to alter (eg, inhibit) ALAS1 expression, such as treatments of subjects with porphyria. Claim 1: A double stranded ribonucleic acid (dsRNA) for inhibiting the expression of ALAS1, wherein said dsRNA comprises a sense strand and an antisense strand, where the antisense strand comprises a region of complementarity with an ALAS1 RNA transcript (for example , SEQ ID No. 1), whose antisense chain comprises at least 20 contiguous nucleotides of the antisense sequence of UAAGAUGAGACACUCUUUCUGGU (SEQ ID No. 4153) or UAAGAUGAGACACUCTUUCUGGU (SEQ ID No. 4154).

ARP200101035A 2013-10-04 2020-04-13 COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF THE ALAS1 GENE AR118658A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361887288P 2013-10-04 2013-10-04

Publications (1)

Publication Number Publication Date
AR118658A2 true AR118658A2 (en) 2021-10-20

Family

ID=58698725

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP140103699A AR097920A1 (en) 2013-10-04 2014-10-03 COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF GENE SINTASA 1 OF 5-AMINOLEVULIN ACID (ALAS1)
ARP200101035A AR118658A2 (en) 2013-10-04 2020-04-13 COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF THE ALAS1 GENE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP140103699A AR097920A1 (en) 2013-10-04 2014-10-03 COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF GENE SINTASA 1 OF 5-AMINOLEVULIN ACID (ALAS1)

Country Status (2)

Country Link
AR (2) AR097920A1 (en)
MA (1) MA39000B1 (en)

Also Published As

Publication number Publication date
AR097920A1 (en) 2016-04-20
MA39000B1 (en) 2018-12-31
MA39000A1 (en) 2018-05-31

Similar Documents

Publication Publication Date Title
CO2017007335A2 (en) Suppression of the arni-induced huntingtin gene
AR090869A1 (en) SERPINC1 RNAi COMPOSITIONS AND THEIR METHODS OF USE
PE20171763A1 (en) COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF THE HAO1 GENE (HYDROXIACIDE-OXIDASE 1 (GLYCOLATE-OXIDASE))
PE20210921A1 (en) ARNI AGENTS AS INHIBITORS OF SERPINE 1 TRANSCRIPTION AND COMPOSITIONS THAT INCLUDE THEM
EA201991369A1 (en) MODIFIED RNA GUIDES
CR20150493A (en) AMRI COMPOSITIONS AGAINST COMPONENT C5 OF THE COMPLEMENT AND METHODS FOR USE
CO2018006590A2 (en) Methods and compositions for the treatment of a disorder associated with serpinc1
AR100946A1 (en) COMPOSITIONS AND METHODS TO REGULATE GENE EXPRESSION THROUGH RNA INTERFERENCE
CO2020015314A2 (en) Arni compositions against angiotensinogen (agt) and methods for their use
CO6690786A2 (en) Polynucleotides and polypeptides encoding abc transporters and modifying their activity in vegetables
AR090825A1 (en) MicroRNA COMPOSITE AND METHODS OF MODULATION OF miR-21 ACTIVITY
MX2013011177A (en) Compositions and methods for inhibiting expression of tmprss6 gene.
CR20160195A (en) COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF GEN ALAS 1
MX2016004230A (en) Compositions and methods for inhibiting expression of the lect2 gene.
CL2021002842A1 (en) Inhibitory double-stranded nucleic acid molecules with shortened sense strands
AR083445A1 (en) siRNA AGAINST FIBROSIS
AR079649A1 (en) COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF GENES IL-18
AR118658A2 (en) COMPOSITIONS AND METHODS TO INHIBIT THE EXPRESSION OF THE ALAS1 GENE
CL2022000539A1 (en) Compositions and methods for inhibiting lect2 gene expression
AR091611A1 (en) OBJECT GENES FOR THE CONTROL OF NUMBER PARASITES OF PLANTS AND THEIR USE
UA114603C2 (en) P0 gene silencing constructs and use
AR090582A1 (en) METHODS AND COMPOSITIONS TO TREAT CANCER USING ARNhc SRC 3 BIFUNCTIONAL
AR121850A2 (en) LPA RNA INTERFERENCE AGENT (RNAi), USE OF SAID AGENT AND METHOD FOR INHIBITING LPA EXPRESSION
AR088562A1 (en) METHODS AND COMPOSITIONS TO SILENCE GENES USING MICRO ARN ARTIFICIALS
CL2018000872A1 (en) Methods of preserving the biological activity of ribonucleic acids.